MCRN Clinical Trials
Bringing Game-Changing Therapies to Canadian Patients: Updates on the Myeloma Canada Research Network's Active Clinical Trials
The Myeloma Canada Research Network (MCRN) brings innovative Canadian-designed clinical trials to hundreds of patients in 24 centres in 9 provinces across Canada. All MCRN trials are designed to improve Canadian myeloma treatment protocols, influence government decision-making policies for drug reimbursement and provide access to game-changing therapies that would otherwise not be available. The goal of these initiatives is to improve overall outcomes for Canadian patients living with myeloma.